A meta-analysis of the difference in response to trastuzumab-deruxtecan (T-DXd) based on HER2 immunohistochemistry (IHC) in HER2 low metastatic breast cancer (mBC)

被引：0

作者：

Kumar, Prashanth Ashok

Sandhu, Michael

Sravanthi, Metlapalli Venkata

Kumar, Vishnu Charan Suresh

Benjamin, Sam

机构：

[1] SUNY Upstate Univ Hosp, Syracuse, NY USA

[2] SUNY Upstate Med Univ, Syracuse, NY USA

[3] SUNY Upstate Med Ctr, Syracuse, NY USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e13164

引用

页数：1